FDA Approves Lilly ' s Ultra-Rapid-Acting Insulin, Lyumjev FDA Approves Lilly ' s Ultra-Rapid-Acting Insulin, Lyumjev

The novel rapid-acting formulation of insulin lispro is approved for adults with type 1 and type 2 diabetes.FDA Approvals

Source: Medscape Diabetes Headlines - June 18, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news